Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › About Us › Our Staff › staff reporter

staff reporter

Email
[email protected]

Articles Authored by staff reporter

Feb 25, 2021

In Brief This Week: BioReference Laboratories, Hologic, Invitae, Danaher, and More

News items for the in vitro diagnostics industry for the week of Feb. 22, 2021.

Feb 25, 2021

Natera Revenues Grow 35 Percent in Q4

The company reported $112.4 million in revenues compared to $83.2 million in Q4 2019, beating the average Wall Street estimate of $106.6 million.

Feb 25, 2021

NantHealth Q4 Revenues Flat From Year Ago

The firm posted total software-related revenues of $18.6 million, up 1 percent from $18.4 million in Q4 2019.

Feb 25, 2021

GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales

GenMark said its ePlex molecular diagnostic product revenue for Q4 was $45.4 million, an increase of 138 percent over the fourth quarter of 2019.

Feb 25, 2021

German Nucleic Acid Sample Prep Startup Rides COVID-19 Testing, Automation Waves

Premium

The company's nucleic acid extraction kits have offered labs relief from COVID-19-related shortages of traditional silica-based bind-wash-elute assays.

Feb 25, 2021

Luminex Shares Surge on Rumor of Acquisition by DiaSorin

Investors responded to a report on Thursday that DiaSorin is considering the purchase of Luminex, one of its in vitro diagnostic testing competitors.

Feb 25, 2021

Oncocyte Closes Second and Final Investment in Razor Genomics Acquisition

Oncocyte is now the sole shareholder of Razor, which developed the DetermaRx test that has now become the firm's flagship clinical offering.

Feb 25, 2021

Biocartis Reports 15 Percent Rise in 2020 Revenues

For the 12 months ended Dec. 31, 2020, Biocartis' revenues rose to €43.1 million ($52.7 million) from €37.4 million in 2019. 

Feb 25, 2021

Novacyt Obtains CE Mark for Extraction-Free COVID-19 PCR Test

The firm said its test eliminates the need for automated extraction systems in a high-volume PCR laboratory, reducing processing time, cost, and labor.

Feb 25, 2021

Kaya 17 Gets CE Mark for Point-of-Care Coronavirus Antigen Test

The company said it intends to pursue Emergency Use Authorization from the US Food and Drug Administration for the test and that it is planning an IPO.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.